Variable selection for individualised treatment rules with discrete outcomes
Abstract An individualised treatment rule (ITR) is a decision rule that aims to improve individuals’ health outcomes by recommending treatments according to subject-specific information. In observational studies, collected data may contain many variables that are irrelevant to treatment decisions. I...
        Saved in:
      
    
          | Published in | Journal of the Royal Statistical Society Series C (Applied Statistics) Vol. 73; no. 2; pp. 298 - 313 | 
|---|---|
| Main Authors | , , , , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
        US
          Oxford University Press
    
        01.03.2024
     | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 0035-9254 1467-9876 1467-9876  | 
| DOI | 10.1093/jrsssc/qlad096 | 
Cover
| Summary: | Abstract
An individualised treatment rule (ITR) is a decision rule that aims to improve individuals’ health outcomes by recommending treatments according to subject-specific information. In observational studies, collected data may contain many variables that are irrelevant to treatment decisions. Including all variables in an ITR could yield low efficiency and a complicated treatment rule that is difficult to implement. Thus, selecting variables to improve the treatment rule is crucial. We propose a doubly robust variable selection method for ITRs, and show that it compares favourably with competing approaches. We illustrate the proposed method on data from an adaptive, web-based stress management tool. | 
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Conflict of interest: S.M.S. has worked on grants awarded to Kaiser Permanente Washington Health Research Institute (KPWHRI) by Bristol Meyers Squibb and by Pfizer. She was also a co-investigator on grants awarded to KPWHRI from Syneos Health, which represented a consortium of pharmaceutical companies carrying out U.S. Food and Drug Administration-mandated studies on the safety of extended-release opioids.  | 
| ISSN: | 0035-9254 1467-9876 1467-9876  | 
| DOI: | 10.1093/jrsssc/qlad096 |